Most popular option
And even with ramped up production, these drugs would likely only reach 10% of adults who could benefit from GLP medications in the next five years, the WHO said in a press release
Only a minority of studies, that is, four in Parkinsons disease 52,53,54,55 , five in substance-use disorders 111,113,115,116,117 , one in psychotic disorders 144 and two in mood disorders 178,179,182 , assessed the cognitive and mental health effects of GLP-1RAs in non-diabetic, non-obese populations
BPC-157 has been shown to counteract NSAID-induced gastrointestinal damage in animal models (Sikiric et al., 2016)
You can use ALCAR to enhance your mitochondrial function, cognition, workouts and more
Both peptides are sensitive to the same degradation pathways and require the same handling rigor